An Outbreak of Respiratory Syncytial Virus Infections in an Outpatient Cancer Unit: Clinical Characteristics and Molecular Investigations

Kothari, Atul; Kennedy, Joshua L.; Hardin, Olga; Burgess, Mary Jo; Crescencio, Juan Carlos Rico; Rettiganti, Mallikarjuna; Susanibar-Adaniya, Sandra P.; Davies, Faith E.; Morgan, Gareth J.; Vanrhee, Frits; Zangari, Maurizio; Schinke, Carolina; Thanendrarajan, Sharmilan; Dinwiddie, Darrell L.

doi:10.1093/ofid/ofw194.16

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…NGS combined with clinical epidemiologic data will provide a greater insight into the potential for different respiratory viral pathogens to spread within a nosocomial environment. We have previously reported presence of multiple different strains of RSV during an outbreak using the same sequencing technology (8). …”

Section: Discussionmentioning

confidence: 99%

The role of next generation sequencing in infection prevention in human parainfluenza virus 3 infections in immunocompromised patients

Kothari

Burgess

Crescencio

et al. 2017

Journal of Clinical Virology

Self Cite

View full text Add to dashboard Cite

Background Respiratory viral infections are a significant problem in patients with hematologic malignancies. We report a cluster of HPIV 3 infections in our myeloma patients, and describe the utility of next generation sequencing (NGS) to identify transmission linkages which can assist in infection prevention. Objectives To evaluate the utility of NGS to track respiratory viral infection outbreaks and delineate between community acquired and nosocomial infections in our cancer units. Study Design Retrospective chart review conducted at a single site. All patients diagnosed with multiple myeloma who developed symptoms suggestive of upper respiratory tract infection (URTI) or lower respiratory tract infection (LRTI) along with a respiratory viral panel (RVP) test positive for HPIV 3 between April 1, 2016, to June 30, 2016, were included. Sequencing was performed on the Illumina MiSeq™. To gain understanding regarding community strains of HPIV 3 during the same season, we also performed NGS on HPIV3 strains isolated from pediatric cases. Results We saw a cluster of 13 cases of HPIV3 infections in the myeloma unit. Using standard epidemiologic criteria, 3 cases were considered community acquired, 7 cases developed infection during treatment in the cancer infusion center, while an additional 3 developed infections during hospital stay. Seven patients required hospitalization for a median duration of 20 days. NGS enabled sensitive discrimination of the relatedness of the isolates obtained during the outbreak and provided evidence for source of transmission. Two hospital onset infections could be tracked to an index case; the genome sequences of HPIV 3 strains from these 3 patients only differed by a single nucleotide. Conclusions NGS offers a significantly higher discriminatory value as an epidemiologic tool, and can be used to gather real-time information and identification of transmission linkages to assist in infection prevention in immunocompromised patients.

show abstract

Section: Discussionmentioning

confidence: 99%